Ocugen, Inc. (OCGN)
NASDAQ: OCGN · IEX Real-Time Price · USD
1.660
+0.025 (1.53%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Ocugen Market Cap
Ocugen has a market cap or net worth of $427.21 million as of July 22, 2024. Its market cap has increased by 249.31% in one year.
Market Cap
427.21M
Enterprise Value
407.66M
1-Year Change
249.31%
Ranking
Category
Stock Price
$1.66
Market Cap Chart
Since December 3, 2014, Ocugen's market cap has increased from $126.80M to $427.21M, an increase of 236.91%. That is a compound annual growth rate of 13.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 427.20M | 189.63% |
| Dec 29, 2023 | 147.50M | -48.17% |
| Dec 30, 2022 | 284.60M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.67% |
| Dec 31, 2020 | 296.50M | 3,472.29% |
| Dec 31, 2019 | 8.30M | 50.91% |
| Dec 31, 2018 | 5.50M | -88.84% |
| Dec 29, 2017 | 49.30M | 85.34% |
| Dec 30, 2016 | 26.60M | -42.80% |
| Dec 31, 2015 | 46.50M | -60.86% |
| Dec 31, 2014 | 118.80M | -6.31% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EyePoint Pharmaceuticals | 461.93M |
| Voyager Therapeutics | 460.71M |
| Nano-X Imaging | 460.09M |
| Altimmune | 458.04M |
| Nkarta | 455.93M |
| Taysha Gene Therapies | 444.04M |
| Kyverna Therapeutics | 439.34M |
| Aura Biosciences | 438.46M |